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Abstract
Quorum sensing (QS) and nucleotide-based second messengers are vital signaling sys-
tems that regulate bacterial physiology in response to changing environments. Disrupting
bacterial signal transduction is a promising direction to combat infectious diseases, and QS
and the second messengers are undoubtedly potential targets. In Vibrio cholerae, both QS
and the second messenger 3’, 5’—cyclic diguanylate (c-di-GMP) play a central role in con-
trolling motility, motile-to-sessile life transition, and virulence. In this study, we found that
water-soluble extract from the North American cranberry could significantly inhibit V. cho-
lerae biofilm formation during the development/maturation stage by reducing the biofilm
matrix production and secretion. The anti-biofilm effect by water-soluble cranberry extract
was possibly through modulating the intracellular c-di-GMP level and was independent of
QS and the QS master regulator HapR. Our results suggest an opportunity to explore more
functional foods to fight stubborn infections through interference with the bacterial signaling
systems.
Introduction
Quorum sensing (QS) and the nucleotide-based second messengers, especially the cyclic
dinucleotides, are two central signaling systems utilized by many bacteria to regulate their
physiological functions in response to changing environmental conditions or during the devel-
opmental process. Due to their decisive roles in bacterial physiology, QS and the second mes-
sengers have been considered as potential targets for new drug development to tackle the
increasingly grim situation of antibiotic resistance. By blocking the signaling transduction
rather than targeting the essential genes, placing selective pressure on resistant strains of bacte-
ria is avoided. In the past twenty years, natural QS inhibitors (QSIs) have been identified from
a number of organisms, and a list of synthetic QSIs have also been developed in research labs
[1, 2]. In contrast, finding inhibitors of the cyclic dinucleotide-based signaling pathways has
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progressed slowly. To date, only a very limited number of compounds have been characterized
as cyclic dinucleotide signaling inhibitors [3].
In the Gram-negative bacterial pathogen Vibrio cholerae, both QS and the cyclic dinucleo-
tides play a fundamental role in controlling cell motility, biofilm formation, and virulence
gene expression. V. cholerae is the causative agent of a frequently fatal disease called cholera.
Since the first cholera pandemic occurred ~ 200 years ago, the disease has affected millions of
people. With a better knowledge of the disease control and improved water and sanitation
facilities, the disease transmission has been eliminated in the developed countries, yet cholera
remains a threat in many parts of the developing world. An essential component to this patho-
gen’s success and persistence in the environment is its ability to attach to both biotic and abi-
otic surfaces via biofilm formation [4]. Biofilms not only aid in surface attachment, they also
provide a barrier that protects and enhances survival. In human infection, when V. cholerae
enters the body, it must first survive the acidic environment of the stomach and then proceed
to attach to the intestinal wall. Biofilms provide cells resistance to high acidity and therefore
are critical for the transmission and infectivity of V. cholerae [5, 6]. The major component of
V. cholerae biofilm, Vibrio polysaccharide, is synthesized by enzymes encoded in the two vps
(Vibrio polysaccharide synthesis) gene operons (vps-I and vps-II) [7, 8]. Additionally, genes
from the intergenic region of the two operons (rbmA, rbmB, and rbmC) as well as bap1, which
is located downstream of vps-II, are involved in the production of matrix proteins and mainte-
nance of the biofilm structure. RbmA provides cell-cell adhesion, RbmC and Bap1 form the
envelopes to encase the cell clusters, and RbmB, whose function is yet to be characterized, is
proposed to help with the detachment of bacteria from mature biofilms [9–11]. The two vps
operons are positively regulated by two major transcriptional regulators, VpsR and VpsT [12,
13], and rbmA, rbmB, rbmC, and bap1 are positively regulated by VpsR [11, 14]. Expression of
vpsR and vpsT is regulated by the cell density through the upstream QS pathway, and by the
intracellular concentration of 3’, 5’—cyclic diguanylate (c-di-GMP), an important second mes-
senger identified in a wide variety of bacteria [15–17].
Unlike many other pathogenic bacteria that cause persistent infections in which QS typi-
cally activates biofilm formation and virulence at high cell density, in V. cholerae, genes
involved in biofilm formation and virulence are maximally expressed at low cell density and
are turned off at high cell density. This unique system is thought to aid in V. cholerae’s life
cycle during acute infection, allowing it to colonize in the intestine and promoting infection at
low cell density, and helping the bacteria detach and transition back to its natural environment
at high cell density [5, 18, 19]. V. cholerae responds to at least two QS signaling molecules
(called autoinducers), CAI-1 and AI-2, through the response regulator LuxO. At low cell den-
sity, LuxO is in the phosphorylated form and activates expression of a set of small regulatory
RNAs, which in turn inhibits expression of the major QS regulator HapR, allowing expression
of vpsR, vpsT, as well as virulence genes. At high cell density, LuxO is dephosphorylated; thus
HapR is de-repressed and inhibits biofilm and virulence genes.
In V. cholerae, increasing the intracellular c-di-GMP level promotes the transition from
motile to sessile lifestyle [20–22]. C-di-GMP has been shown to regulate both the initial attach-
ment and biofilm matrix formation. Binding of c-di-GMP to the ATPase MshE promotes the
polymerization of the MshA subunits to form the pili, which are critical for initial surface
attachment [23]. Both the transcription activators VpsR and VpsT can sense c-di-GMP and
directly bind to it, leading to activation of biofilm genes [24, 25]. C-di-GMP is synthesized by
the diguanylate cyclases (DGCs) containing a GGDEF domain and degraded by the phospho-
diesterases (PDEs) containing either an EAL or HD-GYP domain [26]. The V. cholerae
genome encodes 31 proteins with the GGDEF domain, 12 proteins with the EAL domain, nine
proteins with the HD-GYP domain, and ten proteins with both GGDEF and EAL domains
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[27, 28]. Prior research has identified a list of DGCs and PDEs involved in regulating V. cho-
lerae c-di-GMP level and biofilm formation [21, 29, 30]. Many DGCs and PDEs have N-termi-
nal sensory input domain, indicating their activities could be modulated by various
environmental signals, which in turn affects the intracellular c-di-GMP level [28].
Previously, we reported that supplementation of water-soluble cranberry extract standard-
ized to 4.0% proanthocyanidins (WCESP) to Caenorhabditis elegans, a nematode model, could
significantly enhance the host’s resistance to infection by various bacterial pathogens including
Vibrio cholerae. Mechanistic studies showed that the WCESP-mediated protection was mainly
through promoting the host’s innate immunity. Under our experimental condition, WCESP
treatment did not affect the growth of V. cholerae or expression of the major bacterial virulence
genes, but a slight reduction of bacterial colonization within C. elegans intestine was noticed
[31]. In this study, we tested WCESP’s ability to inhibit V. cholerea biofilm formation and fur-
ther investigated the inhibition mechanism. We found that low concentration of WCESP
could significantly impede V. cholerae biofilm formation during the development/maturation
stage; this inhibition is independent of the QS pathway but is possibly through modulating the
intracellular c-di-GMP level. This study suggests that cranberry contains certain active constit-
uents that can interfere with V. cholerae c-di-GMP signal transduction and provides a poten-
tial means to control V. cholerae biofilm.
Material and methods
Plasmids, bacterial strains, and growth media
The plasmid pBAD33 was obtained from Coli Genetic Stock center (CGSC), and pAT1662
(pBAD33::VCA0956-His6) was obtained from Dr. Andrew Camilli (Tufts University) [32].
The V. cholerae strains (except the MO10 strain) used in this study were all derived from the
wild-type C6706 strain (O1 serotype El Tor isolated from Peru) [33]. The C6706 with PhapR-
lacZ fusion, luxO- (luxO deletion), hapR- (hapR deletion), luxOC (constitutively active LuxO),
cqsA- (cqsA deletion), luxS- (luxS deletion), cqsA-/luxS- (cqsA and luxS double deletion) strains
were obtained from Dr. Jay Zhu (University of Pennsylvania) [5, 19, 34]. The MO10 strain
(serotype O139) was isolated during the cholera outbreak in India and Bangladesh in 1992
[35, 36], also obtained from Dr. Jay Zhu. Other bacterial strains used in this study were
Staphylococcus aureus (S. aureus, ATCC#25923), Pseudomonas aeruginosa (P. aeruginosa,
ATCC#27853), Enterococcus faecalis (E. faecalis, ATCC#47077), Salmonella typhimurium (S.
typhimurium, ATCC#14028), E. coli O157:H7 (ATCC#700927), Listeria monocytogenes (L.
monocytogenes) ScottA (serotype 4b), and L. monocytogenes Mac (serotype 1/2a). The E. coli,
V. cholerae, P. aeruginosa, and S. typhimurium strains were cultured in Lysogeny broth (LB).
The S. aureus, E. faecalis, and L. monocytogenes strains were cultured in brain-heart infusion
(BHI) medium.
Preparation of water-soluble cranberry extract
The cranberry extract used in this study was obtained from Naturex-DBS, LLC (Sagamore,
MA, USA) as described in previously published studies [31]. A stock solution of WCESP was
freshly prepared by dissolving the powder in distilled water to a concentration of 50 mg/ml
immediately before use.
Biofilm growth and quantification
Overnight bacterial cultures were inoculated (1:100 dilution) into 1 ml of LB or BHI medium
in the presence or absence of 2 mg/ml of WCESP and incubated statically in polystyrene tubes
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for 24 hours to allow biofilm development. The temperatures used to develop biofilms were
25˚C for V. cholerae, and 37˚C for other bacterial strains. Quantifications of sessile/biofilm
cells were conducted by the crystal violet staining method and the direct enumeration of live
cells. For the staining method, the planktonic bacterial cells were carefully removed from
each tube, and the tube was washed twice with PBS. The sessile bacterial cells were stained
with 1% crystal violet for 30 minutes, followed by distilled water wash for five times. To enu-
merate biofilm bacterial cells, planktonic cells were carefully removed from underneath the
biofilm pellicle. The pellicle and surface-attached cells were washed twice with PBS and resus-
pended in 1 ml of PBS. The cells were vortexed with glass beads (ϕ = 1mm) for two minutes to
disrupt the biofilm and then plated onto LB agar plates with proper dilutions. Colonies were
counted on the second day. In a parallel set of experiments, total bacterial cells (both plank-
tonic and biofilm cells) were measured by first vortexing the cells with glass beads and then
plating onto LB agar plates with proper dilutions. Data shown are the average results from
three independent experiments, and triplicate samples were tested each time. The data were
pooled and analyzed using unpaired Student’s t-test. A p-value< 0.05 was accepted as statisti-
cally significant.
Biofilm inhibition in pre-established V. cholerae culture
The overnight culture of V. cholerae was inoculated into 1ml of LB in polystyrene test tubes
(1:100 dilution) and incubated statically at 25˚C for 4 hours. Then, 40 μl of WCESP stock solu-
tion (50 mg/ml) was added to the test tubes to reach a final concentration of 2 mg/ml. In the
control tubes, 40 μl of sterile ddH2O was added. The tubes were incubated at 25˚C under static
condition for the remaining 20 hours. Biofilm cells were measured using the standard plate
count method as described above. Data shown are the average results from three independent
experiments, and triplicate samples were tested each time. The data were pooled and analyzed
using unpaired Student’s t-test. A p-value < 0.05 was accepted as statistically significant.
Motility assay
Overnight cultures of V. cholerae were inoculated into 1 ml of LB with or without 2 mg/ml
WCESP in polystyrene test tubes (1:100 dilution). Cultures were incubated with shaking at 150
rpm at 25˚C until reaching mid-log phase. Three microliters of the culture were dropped onto
motility assay plates (LB with 0.3% agar). The plates were incubated at 25˚C. The diameters of
the motility zones were measured after 4 and 24 hours, respectively.
Cell-surface hydrophobicity measurement
The cell-surface hydrophobicity was measured based on the method described by Prabu et al.
[37]. Overnight V. cholerae C6706 culture was inoculated (1:100 dilution) into LB with or
without 2 mg/ml of WCESP and incubated at 25˚C with gentle shaking. Cell samples were col-
lected at 4 and 24 hours respectively and washed twice with 0.85% NaCl. Samples were then
transferred to glass test tubes and resuspended in 3 ml of 0.85% NaCl. Spectrophotometer
reading was then taken from each sample at 600nm and recorded as the OD Initial. Next, 0.25
ml of toluene was added to each sample and vortexed for 2 minutes. Samples were then
allowed to equilibrate at room temperature for 30 minutes. Following the complete separation
of the toluene phase from the aqueous phase, OD of the aqueous phase of each sample was
measured at 600nm and recorded as the OD Final. The Hydrophobicity Index (HPBI) was
then calculated using the following formula: HPBI = (OD Initial—OD Final) / OD Initial x
100%. Data shown are the average results from three independent experiments, and triplicate
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samples were tested each time. The data were pooled and analyzed using unpaired Student’s t-
test. A p-value < 0.05 was accepted as statistically significant.
β-galactosidase assay for PhapR-lacZ
The overnight culture of V. cholerae C6706/PhapR-lacZ was inoculated into LB medium (1:100
dilution) with or without 2 mg/ml WCESP. Cultures were incubated statically at 25˚C, and 1
ml of planktonic bacterial sample was collected at 4, 8, 16, and 24 hours, respectively. The β-
galactosidase activity of each sample was measured according to the method developed by
Miller [38]. Data shown are the average results from three independent experiments, and trip-
licate samples were tested each time. The data were pooled and analyzed using unpaired Stu-
dent’s t-test. A p-value < 0.05 was accepted as statistically significant.
Gene expression analysis by quantitative real-time PCR (qRT-PCR)
Overnight V. cholerae C6706 culture was inoculated (1:100 dilution) into 1 ml of LB with or
without 2 mg/ml WCESP. Cultures were grown statically at 25˚C. Planktonic bacterial samples
were harvested after 4 and 24 hours of incubation and washed once with PBS. Total RNA was
prepared using RNAzol RT reagent (Molecular Research Center, INC.) and stored at -80˚C.
Complementary DNA was synthesized using the iScript cDNA synthesis kit (Bio-Rad).
qRT-PCR was performed using SensiFAST SYBR No-Rox Kit (Bioline) and the CFX96 real-
time PCR detection system according to the manufacturer’s suggested protocol (Bio-Rad). The
qRT-PCR conditions were: 95˚C for 2 minutes, followed by 40 cycles of 5 seconds at 95˚C, 10
seconds at 50˚C, and 15 seconds at 72˚C. 16S rRNA was used as the endogenous control to
normalize the expression levels of target transcripts [31]. Relative fold-changes for transcripts
were calculated using the comparative CT (2−ΔΔCT) method [39]. Cycle thresholds of amplifi-
cation were determined by Light Cycler software (Bio-Rad). Each qRT-PCR experiment was
repeated three times using independent RNA preparations. The data were pooled and analyzed
using unpaired Student’s t-test, and a p-value< 0.05 was accepted as statistically significant.
The primers used in this study are listed in Table 1.
c-di-GMP quantification assay
The thiazole orange (TO)-based fluorescent detection method was used to quantify the intra-
cellular c-di-GMP level [40]. In brief, overnight V. cholerae C6706 culture was inoculated
(1:100 dilution) into LB medium and incubated statically at 25˚C. The planktonic cells from
the static cultures were collected at 4h, 8h, 16h, and 24h time-points to represent the key
growth phases, and the total cell number in each sample was determined using the plate count
method. Bacterial cells were pelleted by centrifugation and resuspended in 1 ml of 10 mM
Tris-HCl (pH 8.0) buffer containing 100 mM NaCl. The cells were lysed by sonication. Tri-
chloroacetic acid was added to the cell lysate to a final concentration of 12% to precipitate cel-
lular macromolecules. The suspension was incubated on ice for 10 minutes and neutralized by
3 M KOH containing 0.4 M Tris and 2 M KCl, followed by centrifugation at full speed for 10
minutes. The supernatant was filtered through a 0.2 μm filter and then 1:10 diluted into the
reaction buffer (10 mM Tris-HCl (pH 8.0) containing 1M NaCl), incubated at 95˚C for 5 min-
utes, and cooled to room temp. TO was then added to each sample at a working concentration
of 30 μM and incubated at 4˚C for 12h until fluorescence readings were taken at excitation and
emission wavelengths at 508nm and 557nm, respectively. The concentration of c-di-GMP was
calculated using a calibration curve and normalized to 1 x 109 bacterial cells in 1 ml.
Cranberry extract inhibits Vibrio cholerae biofilm formation
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Results
WCESP at non-lethal concentration specifically inhibits V. cholerae biofilm
formation
To test whether WCESP could affect V. cholerae biofilm formation, we grew V. cholerae wild-
type C6706 strain statically in LB medium at 25˚C, a temperature that more closely resembles
the natural condition. WCESP was added into the growth medium at the same time during
inoculation to reach a final concentration of 2 mg/ml. After incubation for 24 hours, the out-
come of adding WCESP was palpable. As shown in Fig 1A, a thick pellicle was formed at the
air-liquid interface in the control tube but not in the tube with WCESP. The bacterial culture
in the WCESP tube also showed higher turbidity than that in the control tube, indicating that
most of the bacterial cells remained in the planktonic form when WCESP was added into the
medium. A standard plate count method was used to enumerate the bacterial cells in the pelli-
cles and those attached to the wall of the culture tubes from both tubes, i.e., biofilm cells. An
apparent reduction of cell numbers was observed in the WCESP tube (Fig 1B). In a parallel set
Table 1. Oligos used in qRT-PCR.
Oligo Sequence
16S rRNA-F 5'-GGAAACGATGGCTAATACCG-3'
16S rRNA-R 5'-GCCCTTACCTCACCAACTAG-3'
bap1-F 5'-CGCTGGCACACTAAACAA G-3'
bap1-R 5'-CCATACATTCATACCCAAGAGC-3'
epsE-F 5'-CTAACCCAAGTCTATCAG-3'
epsE-R 5'-AATCTTCGTTTTGAGGC-3'
flaA-F 5'-GGATTAAAGATACGGATTTTG-3'
flaA-R 5'-CGAGATTGCAGAGTTTG-3'
hapR-F 5'-CGATTGTCACTGGCTCAAAG-3'
hapR-R 5'-GCAGTTGGTTAGTTCGGTTG-3'
luxO-F 5'-GCGAAAGTGGTACAGGTAAAG-3'
luxO-R 5'-CCCTTTGACGTGACCAAAC-3'
mshA-F 5'-CATTGCCCATAAGTTTG-3'
mshA-R 5'-GTTCCTGTAGACGATTG-3'
pomB-F 5'-CTCTTGCTCTCGTTTTC-3'
pomB-R 5'-AATACTGGTCCCTTTGG-3'
rbmA-F 5'-TGGGTTCCAGAGTATATG-3'
rbmA-R 5'-GAGTTCAGGTAGGCTATT-3'
rbmB-F 5'-CAGCAGGAACAGAAATG-3'
rbmB-R 5'-CCTTAGCTCCTCTAGTATC-3'
rbmC-F 5'-CGAGCAATAAGAAAGTGG-3'
rbmC-R 5'-GCCTTCAACTAACCAAC-3'
vpsD-F 5'-CATCCAAGAGCAACTGAAAG-3'
vpsD-R 5'-GCAAGGTCAACACATTACGAG-3'
vpsL-F 5'-TTCTTTACATACGGCATTC-3'
vpsL-R 5'-GCCAATAAAAGAACCGAC-3'
vpsR-F 5'-GGCCATGTATTGGTATTGTGG-3'
vpsR-R 5'-GGCAAATGGTATCTGAACTGAG-3'
vpsT-F 5'-GTCCGCAGGATATTGAGCAT-3'
vpsT-R 5'-GCCTTTGATCAGGGTATCCA-3'
https://doi.org/10.1371/journal.pone.0207056.t001
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of tubes, we quantified the total bacterial cells (both planktonic and biofilm cells) in the pres-
ence or absence of 2 mg/ml of WCESP by plate counting during the 24-hour time course. No
visible difference in cell numbers was detected, indicating the WCESP concentration used in
the biofilm inhibition assays did not cause any growth defects, which is consistent with our
previous results (S1 Table) [31]. Considering that V. cholerea is a human pathogen, we also
tested WCESP’s ability to inhibit biofilm at 37˚C. A similar inhibition effect was observed as
well (S1 Fig).
To test whether the biofilm inhibition by WCESP is a general feature towards a broad spec-
trum of bacterial pathogens, we examined seven other bacterial species including both Gram-
positive and Gram-negative bacteria from our lab collections. No inhibition of biofilm forma-
tion by 2 mg/ml of WCESP was observed for any of the seven tested strains (Fig 1B). The wild-
type V. cholerae strain used in our experiments is a clinical isolate belonging to the O1 serotype
El Tor biotype. We further tested the WCESP’s impact on a V. cholerae MO10 strain, which
belongs to the O139 serotype by a quick crystal violet staining method. Strong inhibition of
biofilm formation by WCESP was detected (Fig 1C). Thus, our results revealed that at non-
lethal concentration, WCESP specifically inhibits V. cholerae biofilm formation.
Fig 1. WCESP inhibits V. cholerae biofilm formation. The bacterial cultures were incubated for 24 hours without shaking in the absence and
presence of 2 mg/ml of WCESP. (A) Biofilm pellicle formed at the air-water interface in the absence of WCESP, but not in the presence of WCESP. (B)
Quantification of the pellicle and surface-attached bacterial cells of V. cholerae C6706 and other pathogenic bacteria in the presence and absence of
WCESP. Results shown are the average of three independent experiments, and triplicate samples were tested each time; error bars are standard error
of the mean. (� indicates p< 0.05). (C) Crystal violet staining results of surface-attached V. cholerae bacterial cells.
https://doi.org/10.1371/journal.pone.0207056.g001
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WCESP impedes mainly the development/maturation stage of V. cholerae
biofilm formation
Biofilm formation is generally divided into initiation, development/maturation, and disper-
sion stages. Flagellar motility and the mannose-sensitive haemagglutinin type IV pilus
(MSHA) are crucial for the initial attachment to abiotic surfaces, and the flagellum also medi-
ates the spread across the surface area [41]. Mass production of exopolysaccharide (EPS) and
matrix proteins is associated with the development of the three-dimensional structures during
the maturation stage. To test which stage or stages were possibly affected by the addition of
WCESP, we first performed a motility assay. The wild-type V. cholerae C6706 was grown to
mid-log phase with shaking in the presence or absence of WCESP, and then 3 μl of the bacte-
rial culture were dropped onto the motility agar plate and incubated at room temperature. The
diameters of the motility zones were measured after 4 and 24 hours. As shown in Table 2, add-
ing WCESP to the growth medium did not hinder flagellar motility. We further compared the
expression of flaA (encoding the core flagellin), pomB (encoding the flagellar motor protein),
and mshA (encoding the type IV pilus) in the presence or absence of WCESP using qRT-PCR.
No noticeable changes were detected after either 4 hours (S2 Fig) or 24 hours of WCESP treat-
ment (Fig 2). These results suggested that WCESP does not interfere with the initial attach-
ment stage. We reasoned that if the initiation stage is not affected, we would see the same
degree of inhibition if WCESP were added into a static culture that has already passed the first
stage (we named it “pre-established culture”). As expected, the inhibition of a 4 hour-pre-
established culture was evident and comparable to the result obtained when WCESP was
added at inoculation (Fig 3). The same level of inhibition was also achieved on a 6 hour-pre-
established culture. Together, these data indicated that WCESP impedes mainly the develop-
ment/maturation stage of V. cholerae biofilm formation.
WCESP reduces V. cholerae cell-surface hydrophobicity, VPS, and major
matrix proteins production and secretion
Bacterial cell-surface hydrophobicity (CSH) depicts the tendency of a bacterial cell to aggregate
with cells of similar hydrophobicity as opposed to water, which is mainly affected by the bacte-
rial cell surface composition and structure [42]. CSH also influences bacterial surface adhesion
and biofilm development. Early study by Dahlba¨ck et al. showed that the hydrophobic interac-
tions among bacteria played an important role in their initial adhesion at the air-water inter-
face [43]. In V. cholerae, the biofilm matrix protein Bap1 is the crucial determinant of pellicle
mechanical strength and hydrophobicity, allowing the pellicle to spread and remain at the air-
liquid interface [44]. To test whether WCESP would change CSH, we incubated V. cholerae
C6706 with and without 2 mg/ml WCESP and collected bacterial samples after 4 and 24 hours
for the CSH measurement. As shown in Fig 4, there was no obvious difference of the
Table 2. The diameters of the motility zones.
T = 4 hr T = 24 hr
no WCESP 0.30 ± 0.00 cm 16.17 ± 0.29 cm
WCESP (2mg/ml) in the brotha 0.32 ± 0.03 cm 15.83 ± 0.29 cm
WCESP (2mg/ml) in the agarb 0.30 ± 0.00 cm 16.67 ± 0.29 cm
Note: The data shown are the average results from three repeats.
a V. cholerae was cultured in the presence of WCESP until mid-log phase then dropped onto the motility plate.
b V. cholerae was cultured in the absence of WCESP until mid-log phase then dropped onto the motility plate which
contains WCESP.
https://doi.org/10.1371/journal.pone.0207056.t002
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Fig 2. qRT-PCR analysis of V. cholerae biofilm-related genes in response to 2 mg/ml WCESP (normalized to 16S
rRNA). Results are the average of three independent experiments, and error bars are standard error of the mean. (�
indicates p< 0.05).
https://doi.org/10.1371/journal.pone.0207056.g002
Fig 3. WCESP impedes mainly the development stage of V. cholerae biofilm formation. Inhibition of 4-hr pre-
established biofilm formation by 2 mg/ml WCESP. Results shown are the average of three independent experiments,
and triplicate samples were tested each time; error bars are standard error of the mean. (� indicates p< 0.05).
https://doi.org/10.1371/journal.pone.0207056.g003
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hydrophobicity index (HPBI) between the 4-hour samples. But after 24 hours, the WCESP
treated cells had a significant decrease of CSH (HPBI = 26.6 ± 3.3 vs. 41.3 ± 3.2 of untreated
cells).
Using qRT-PCR, the expression of genes that are responsible for the production of VPS and
matrix proteins was compared in the presence and absence of WCESP at 4 and 24 hours. No
significant difference was detected at 4 hr. At 24 hr, downregulation of the vpsD (the fifth gene
of the vps-I operon), vpsL (the first gene of the vps-II operon), as well as genes encoding the
matrix proteins bap1, rbmA, rbmB, and rbmC, was evident in the presence of WCESP (Fig 2).
Expression of the two transcriptional activators of the vps and rbm operons, VpsT and VpsR,
was also measured. While vpsT expression showed a 12.5-fold decrease, vpsR transcription
only slightly declined (1.9-fold). The extracellular protein secretion (eps) system plays a vital
role in V. cholerae pathogenesis and environmental survival; it is involved in exporting toxins
and VPS across the outer membrane [45]. Expression of epsE (the third gene of the eps operon)
was measured to denote the change of the eps operon when exposed to WCESP. As shown in
Fig 2, a 3.8-fold of decrease was observed when WCESP was added to the growth medium.
These results suggested WCESP reduces the production and secretion of VPS and major
matrix proteins.
WCESP-mediated biofilm inhibition is independent of HapR and the
quorum-sensing pathway
QS pathway plays a central role in the regulation of V. cholerae biofilm, and cranberry constit-
uents have been reported to attenuate QS-mediated cell-cell signaling in V. harveyi and P. aer-
uginosa [46–48]. Thus, it is natural to link WCESP’s inhibition of V. cholerae biofilm to the
effects on QS system. In V. cholerae, high cell density (when CAI-1 and AI-2 concentrations
are high) results in downregulation of biofilm formation through AI-sensing, LuxO dephos-
phorylation, and activation the master QS regulator HapR expression. HapR then inhibits
vpsR, vpsT, and the vps-I, vps-II, and rbm genes. We reasoned that if the inhibition is through
Fig 4. WCESP (2 mg/ml) decreases V. cholerae cell-surface hydrophobicity. The Hydrophobicity Index (HPBI) was
calculated using the following formula: HPBI = (OD Initial—OD Final) / OD Initial x 100%. Data shown are the
average results from three independent experiments, and triplicate samples were tested each time; error bars are
standard error of the mean. (� indicates p< 0.05).
https://doi.org/10.1371/journal.pone.0207056.g004
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QS, then (1) WCESP would enhance the expression of HapR, and (2) in QS-deficient mutants
(such as hapR deletion or cqsA, luxS deletions), WCESP would no longer inhibit biofilm for-
mation. To test this, we first examined the hapR transcription using a strain carrying a chro-
mosomal hapR-lacZ fusion [5]. As shown in Fig 5A, hapR transcription was slightly lower (less
than 2-fold) in the presence of WCESP at T = 4, 8, and 16 hr, but at T = 24 hr, hapR transcrip-
tion was marginally higher (1.3-fold). qRT-PCR of hapR from 24 hr WCESP-treated bacterial
culture showed no distinct change (Fig 2). Results from the two experiments indicated
WCESP does not enhance HapR expression. Next, we evaluated biofilm formation in the pres-
ence and absence of WCESP using the plate count method in the following QS-deficient
mutant strains: hapR-, luxOc (in which LuxO is locked into the active form), cqsA- (no CAI-1),
luxS-(no AI-2), and a cqsA- / luxS- double deletion. The luxO- mutant was included to serve as
a biofilm-negative control, as HapR is overexpressed in luxO- and strongly inhibits biofilm for-
mation. The results are shown in Fig 5B, in which strong inhibition of biofilm formation by
WCESP was observed in all tested QS-deficient strains. Taken together, we conclude that
WCESP-mediated biofilm inhibition is independent of HapR and QS pathway.
Fig 5. WCESP-mediated biofilm inhibition is independent of HapR and the quorum-sensing pathway. (A) β-
galactosidase assay of hapR transcription using a V. cholerae C6706 strain carrying a chromosomal hapR-lacZ fusion.
(B) Biofilm formation in the presence and absence of 2 mg/ml WCESP using the plate count method in V. cholerae
C6706 derived mutant strains. Data shown are the average results from three independent experiments, and triplicate
samples were tested each time; error bars are standard error of the mean. (� indicates p< 0.05).
https://doi.org/10.1371/journal.pone.0207056.g005
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WCESP modulates the intracellular concentration of the second messenger
3’,5’ -c-di-GMP
The bacterial second messenger 3’, 5’—cyclic diguanylate (c-di-GMP) is another vital signaling
system in V. cholerae that regulates the planktonic to biofilm transition and the biofilm matrix
production. To examine WCESP’s influence on c-di-GMP, we sought to directly measure the
intracellular c-di-GMP concentration using the thiazole orange (TO)-based fluorescent detec-
tion method [40]. To do this, V. cholerae C6706 was grown statically at 25˚C in the presence
and absence of 2 mg/ml WCESP. The planktonic portion of the static cultures was collected at
4, 8, 16, and 24 hours, respectively. As the bacterial cell number changes during the growth
phase and also is affected by the presence of WCESP, we normalized the final c-di-GMP con-
centration to 1 x 109 bacterial cells in 1 ml. As shown in Fig 6, no difference was found between
the two 4-hr samples (which represent the initiation stage). At T = 8 hr, a slight decrease was
noticeable in the WCESP-treated cells (11.8 ± 1.2 μM) as compared to the control (15.5 ±
1.5 μM). At T = 16 and 24 hr, the difference was remarkable. Results from this experiment sug-
gest that the inhibition of V. cholerae biofilm formation by WCESP is possibly through reduc-
ing the intracellular c-di-GMP level during the development/maturation stage of the biofilm
formation. If this holds true, then increasing the c-di-GMP level would at least partially coun-
teract WCESP’s anti-biofilm effect. To test this, pAT1662 (a plasmid that contains the diguany-
late cyclase VCA0956 gene under the control of the arabinose-inducible araBAD promoter)
[32] was introduced into V. cholerae C6706 by electroporation. Biofilm formation of the result-
ing strain was examined when 0.2% of L-arabinose and 2 mg/ml of WCESP were added to the
growth medium simultaneously. As shown in Fig 7, a partial recovery of the biofilm pellicle
was observed in tube 8 (upper panel). Crystal violet staining also revealed more surface-
attached cells in tube 8 (bottom panel) as compared to tube 6.
Fig 6. Quantification of intracellular c-di-GMP concentration in the presence and absence of 2 mg/ml WCESP
using the thiazole orange (TO)-based fluorescent detection method. The concentration of c-di-GMP was calculated
using a calibration curve and normalized to the concentration of a bacterial culture with 1 x 109 cells/ml. Data shown
are the average results from three independent experiments, and error bars are standard error of the mean.
https://doi.org/10.1371/journal.pone.0207056.g006
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Discussion
Due to the selective pressure of antibiotics, bacterial resistance to antibiotics is becoming an
increasing health threat worldwide. A growing body of evidence demonstrated that plant
extracts offer considerable antimicrobial and anti-biofilm potentials and do not come with the
significant risk of antibiotic resistance. A vast number of phytochemicals have been recognized
as a valuable alternative and complementary medicine to treat bacterial infections [49, 50].
The North American cranberries (Vaccinium macrocarpon) are rich in polyphenols, including
anthocyanins, proanthocyanidins (PACs), flavonoids, and phenolic acid derivatives [51–53].
The antimicrobial activity of cranberry and cranberry products has been well acknowledged,
such as preventing urinary tract disorders [54–56], dental decay [57–60], as well as stomach
ulcers and cancers [61]. There are only a limited number of reports on cranberry’s anti-biofilm
ability; most of these studied the effects on the periodontal pathogenic bacteria [57–59, 62–65]
or the urinary tract infections (UTIs) associated pathogens [66–68]. Cranberry extracts have
also been shown to reduce Staphylococcus epidermidis biofilm formed on soft contact lenses
[69], and Pseudomonas aeruginosa biofilm [70]. Despite all the potential benefits, there is not
enough research on cranberry’s anti-biofilm mechanism. In the present study, we investigated
the effects of WCESP on V. cholerae biofilm formation. Our results indicated that sub-lethal
level of WCESP could inhibit V. cholerae biofilm formation during the development/matura-
tion stage by reducing the production and excretion of VPS and biofilm matrix proteins. We
further investigated the involvement of the two key signaling systems and found that the inhi-
bition is independent of QS and the QS master regulator HapR. On the other hand, the intra-
cellular c-di-GMP level was decreased in the presence of WCESP. Our results imply WCESP’s
anti-biofilm effect is possibly through modulating c-di-GMP signaling, though we could not
rule out the possibility that other regulatory pathways might be involved.
In most bacterial pathogens, biofilm formation is activated at high cell density. Thus, inhi-
bition of QS would result in the reduction of biofilm. But in V. cholerae, this is opposite; inhib-
iting QS (like the hapR deletion or the luxOC strain) would enhance biofilm formation.
Initially, we hypothesized that cranberry extract might promote QS signaling, lead to the acti-
vation of HapR, which inhibits biofilm, but our results didn’t support this idea. Meanwhile,
cranberry constituents have been reported to attenuate QS-mediated cell-cell signaling in V.
harveyi and P. aeruginosa. In V. harveyi, the nondialyzable material (NDM) of cranberry com-
petes with the autoinducer for binding to its receptor [46]. In P. aeruginosa, cranberry-derived
PACs (contains > 95% PACs) inhibits autoinducer production and also antagonizes the acti-
vation of QS transcriptional regulators [48]. These studies showed that the NDM or PACs is
Fig 7. Induction of c-di-GMP synthesis partially restored biofilm formation in the presence of WCESP. The
overnight bacterial culture was 1:100 diluted into 5 ml of fresh LB medium and incubated at 37˚C with shaking until
OD600 reached ~ 0.25. The culture was then aliquoted into four tubes with 1 ml each. WCESP and L-arabinose were
added to the corresponding tubes with a final concentration of 2 mg/ml and 0.2%, respectively. All the tubes were
subsequently incubated at 37˚C for 24 hours without shaking. Tube 1–4, VC6706 with the empty vector pBAD33 to
serve as controls. Tube 5–8, VC6706 with pAT1662 (pBAD33::VCA0956-His6).
https://doi.org/10.1371/journal.pone.0207056.g007
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the major component in cranberry that functions as QS inhibitor. The cranberry extract used
in our study is water-soluble and contain only 4% PACs; this probably explains why we did
not see any impacts on QS signaling but also indicates the aqueous cranberry extract possesses
anti-biofilm activity in a QS-independent mode.
The second messenger c-di-GMP has been identified in almost all major bacterial phyla,
and its role as a signaling molecule involved in a variety of physiological processes has been
well documented [71]. In V. cholerae, c-di-GMP controls motile to sessile transition at both
the initial attachment and the matrix production/development stages. Jones et al. reported that
c-di-GMP promotes the polymerization of MshA subunits to form the MshA pili which are
indispensable for the initial attachment to abiotic surfaces [23]. C-di-GMP also promotes the
biofilm matrix production through interaction with the two key transcriptional activators,
VpsR and VpsT [24, 25]. Since the V. cholerae genome encodes numerous proteins containing
the functional domains for c-di-GMP metabolism, instead of measuring the expression of
individual genes, we directly measured the change of intracellular c-di-GMP concentration
when WCESP is added to the growth medium. The decrease of c-di-GMP was detected in the
8, 16, and 24 hr samples, but not in the 4 hr samples. Consistent with the results from the
motility, qRT-PCR, and pre-established biofilm inhibition assays, this result suggested that the
soluble constituents from WCESP impede the development/maturation stage of biofilm for-
mation through modulating the c-di-GMP level. It’s worth mentioning that we didn’t observe
enhanced motility at 24 hr, when c-di-GMP level was reduced by WCESP. High concentration
of c-di-GMP is known to repress V. cholerea motility [20], thus we should expect to see
enhanced motility if c-di-GMP level is decreased. This discrepancy might reflect the signaling
specificity among different c-di-GMP receptors or binding proteins. We propose multiple
mechanisms might be involved in moderating the c-di-GMP concentration by WCESP. The
active ingredients from WCESP may affect c-di-GMP synthesis and degradation through
downregulating the diguanylate cyclases or upregulating the phosphodiesterases at the expres-
sion level or changing their activities; the active ingredients may also function as a c-di-GMP
sequestrator to compete with the c-di-GMP receptors. In addition, WCESP may affect the
communication between c-di-GMP and its receptor through binding to the receptor protein
or changing its conformation or activity. Studies are underway to elucidate the molecular
mechanisms. Characterization of the active ingredients from WCESP is another focus of our
research.
In this study, we also tested WCESP’s anti-biofilm activity on other pathogenic bacteria,
including four Gram-positive strains (S. aureus, E. faecalis, and two L. monocytogenes strains)
and three Gram-negative bacteria (P. aeruginosa, S. typhimurium, and E. coli O157:H7). No
inhibition was observed in all these strains. In contrast to V. cholerae, QS (high cell density)
promotes biofilm formation in these strains. Because the content of PACs or NDM (the poten-
tial QSI) is quite low in our WCESP sample, there was probably no impact on QS signaling in
these strains. In the three Gram-negative bacteria, c-di-GMP signaling has also been character-
ized to regulate biofilm formation, yet we didn’t see biofilm inhibition effect. Maybe higher
concentrations of WCESP are required, or more importantly, each bacterium has a unique c-
di-GMP signaling network.
Conclusions
Targeting QS or the nucleotide-based second messengers is considered the new hope to
address the growing problem of antibiotic resistance. While various natural and synthetic
compounds have been characterized as QSIs, inhibitors of the cyclic dinucleotide signaling are
still lacking. In this study, we revealed soluble constituents in cranberry extract could inhibit
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V. cholerae biofilm formation possibly through modulating the c-di-GMP level. Although
there are more questions related to the inhibition mechanisms and the active ingredients to be
answered, this work suggests that cranberry, as well as many functional foods, may contain
potent inhibitors of the bacterial nucleotide-based signaling pathway and leads to a new direc-
tion of the functional food study and the antimicrobial and anti-biofilm drug development.
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S1 Fig. WCESP inhibits V. cholerae biofilm formation at 37˚C. The bacterial cultures were
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(TIF)
S2 Fig. qRT-PCR analysis of V. cholerae flaA, pomB, and mshA genes in response to 2 mg/
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pendent experiments, and error bars are standard error of the mean.
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S1 Table. Total V. cholerae cell count (both planktonic and biofilm cells) in the presence or
absence of 2 mg/ml of WCESP during the 24-hour time course. The same experiment was
repeated three times. The data shown are the representative results from one of the experiments.
(DOCX)
Acknowledgments
We would like to thank Dr. Jay (Jun) Zhu for generously providing all the V. cholerae strains,
Dr. Andrew Camilli for providing the pAT1662 plasmid, and Reza Ghaedian (Decas) for pro-
viding the cranberry extract. We thank Joseph Angeloni, Ojas Natarajan, and Zane Williams
for insightful discussion. We appreciate Lauren V. Blakely for initial trials on the experimental
conditions.
Author Contributions
Conceptualization: Min Cao.
Data curation: Min Cao.
Formal analysis: Min Cao.
Funding acquisition: Min Cao.
Investigation: Daniel B. Pederson, Levi B. Blue, Sara V. Smith.
Methodology: Daniel B. Pederson, Min Cao.
Project administration: Min Cao.
Resources: Yuqing Dong, Min Cao.
Supervision: Min Cao.
Validation: Daniel B. Pederson, Min Cao.
Visualization: Yuqing Dong, Min Cao.
Writing – original draft: Daniel B. Pederson, Min Cao.
Writing – review & editing: Yuqing Dong, Min Cao.
Cranberry extract inhibits Vibrio cholerae biofilm formation
PLOS ONE | https://doi.org/10.1371/journal.pone.0207056 November 7, 2018 15 / 19
References
1. Kalia VC. Quorum sensing inhibitors: an overview. Biotechnol Adv. 2013; 31(2):224–45. Epub 2012/11/
09. https://doi.org/10.1016/j.biotechadv.2012.10.004 PMID: 23142623.
2. Rampioni G, Leoni L, Williams P. The art of antibacterial warfare: Deception through interference with
quorum sensing-mediated communication. Bioorg Chem. 2014; 55:60–8. Epub 2014/04/21. https://doi.
org/10.1016/j.bioorg.2014.04.005 PMID: 24823895.
3. Opoku-Temeng C, Zhou J, Zheng Y, Su J, Sintim HO. Cyclic dinucleotide (c-di-GMP, c-di-AMP, and
cGAMP) signalings have come of age to be inhibited by small molecules. Chem Commun (Camb).
2016; 52(60):9327–42. Epub 2016/06/24. https://doi.org/10.1039/c6cc03439j PMID: 27339003.
4. Lutz C, Erken M, Noorian P, Sun S, McDougald D. Environmental reservoirs and mechanisms of persis-
tence of Vibrio cholerae. Front Microbiol. 2013; 4:375. Epub 2013/12/16. https://doi.org/10.3389/fmicb.
2013.00375 PMID: 24379807; PubMed Central PMCID: PMCPMC3863721.
5. Zhu J, Mekalanos JJ. Quorum sensing-dependent biofilms enhance colonization in Vibrio cholerae.
Dev Cell. 2003; 5(4):647–56. PMID: 14536065.
6. Liu Z, Stirling FR, Zhu J. Temporal quorum-sensing induction regulates Vibrio cholerae biofilm architec-
ture. Infect Immun. 2007; 75(1):122–6. Epub 2006/10/30. https://doi.org/10.1128/IAI.01190-06 PMID:
17074850; PubMed Central PMCID: PMCPMC1828391.
7. Yildiz FH, Schoolnik GK. Vibrio cholerae O1 El Tor: identification of a gene cluster required for the
rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc Natl
Acad Sci U S A. 1999; 96(7):4028–33. PMID: 10097157; PubMed Central PMCID: PMCPMC22414.
8. Fong JC, Syed KA, Klose KE, Yildiz FH. Role of Vibrio polysaccharide (vps) genes in VPS production,
biofilm formation and Vibrio cholerae pathogenesis. Microbiology. 2010; 156( Pt 9):2757–69. Epub
2010/05/13. https://doi.org/10.1099/mic.0.040196-0 PMID: 20466768; PubMed Central PMCID:
PMCPMC3068689.
9. Fong JC, Yildiz FH. The rbmBCDEF gene cluster modulates development of rugose colony morphology
and biofilm formation in Vibrio cholerae. J Bacteriol. 2007; 189(6):2319–30. Epub 2007/01/12. https://
doi.org/10.1128/JB.01569-06 PMID: 17220218; PubMed Central PMCID: PMCPMC1899372.
10. Berk V, Fong JC, Dempsey GT, Develioglu ON, Zhuang X, Liphardt J, et al. Molecular architecture and
assembly principles of Vibrio cholerae biofilms. Science. 2012; 337(6091):236–9. https://doi.org/10.
1126/science.1222981 PMID: 22798614; PubMed Central PMCID: PMCPMC3513368.
11. Fong JC, Karplus K, Schoolnik GK, Yildiz FH. Identification and characterization of RbmA, a novel pro-
tein required for the development of rugose colony morphology and biofilm structure in Vibrio cholerae.
J Bacteriol. 2006; 188(3):1049–59. https://doi.org/10.1128/JB.188.3.1049-1059.2006 PMID:
16428409; PubMed Central PMCID: PMCPMC1347326.
12. Yildiz FH, Dolganov NA, Schoolnik GK. VpsR, a Member of the Response Regulators of the Two-Com-
ponent Regulatory Systems, Is Required for Expression of vps Biosynthesis Genes and EPS(ETr)-
Associated Phenotypes in Vibrio cholerae O1 El Tor. J Bacteriol. 2001; 183(5):1716–26. https://doi.org/
10.1128/JB.183.5.1716-1726.2001 PMID: 11160103; PubMed Central PMCID: PMCPMC95057.
13. Casper-Lindley C, Yildiz FH. VpsT is a transcriptional regulator required for expression of vps biosyn-
thesis genes and the development of rugose colonial morphology in Vibrio cholerae O1 El Tor. J Bacter-
iol. 2004; 186(5):1574–8. https://doi.org/10.1128/JB.186.5.1574-1578.2004 PMID: 14973043; PubMed
Central PMCID: PMCPMC344397.
14. Yildiz FH, Liu XS, Heydorn A, Schoolnik GK. Molecular analysis of rugosity in a Vibrio cholerae O1 El
Tor phase variant. Mol Microbiol. 2004; 53(2):497–515. https://doi.org/10.1111/j.1365-2958.2004.
04154.x PMID: 15228530.
15. Jenal U, Malone J. Mechanisms of cyclic-di-GMP signaling in bacteria. Annu Rev Genet. 2006; 40:385–
407. https://doi.org/10.1146/annurev.genet.40.110405.090423 PMID: 16895465.
16. Boyd CD, O’Toole GA. Second messenger regulation of biofilm formation: breakthroughs in under-
standing c-di-GMP effector systems. Annu Rev Cell Dev Biol. 2012; 28:439–62. https://doi.org/10.1146/
annurev-cellbio-101011-155705 PMID: 23057745; PubMed Central PMCID: PMCPMC4936406.
17. Ro¨mling U, Galperin MY, Gomelsky M. Cyclic di-GMP: the first 25 years of a universal bacterial second
messenger. Microbiol Mol Biol Rev. 2013; 77(1):1–52. https://doi.org/10.1128/MMBR.00043-12 PMID:
23471616; PubMed Central PMCID: PMCPMC3591986.
18. Hammer BK, Bassler BL. Quorum sensing controls biofilm formation in Vibrio cholerae. Mol Microbiol.
2003; 50(1):101–4. PMID: 14507367.
19. Zhu J, Miller MB, Vance RE, Dziejman M, Bassler BL, Mekalanos JJ. Quorum-sensing regulators con-
trol virulence gene expression in Vibrio cholerae. Proc Natl Acad Sci U S A. 2002; 99(5):3129–34. Epub
2002/02/19. https://doi.org/10.1073/pnas.052694299 PMID: 11854465; PubMed Central PMCID:
PMCPMC122484.
Cranberry extract inhibits Vibrio cholerae biofilm formation
PLOS ONE | https://doi.org/10.1371/journal.pone.0207056 November 7, 2018 16 / 19
20. Srivastava D, Hsieh ML, Khataokar A, Neiditch MB, Waters CM. Cyclic di-GMP inhibits Vibrio cholerae
motility by repressing induction of transcription and inducing extracellular polysaccharide production.
Mol Microbiol. 2013; 90(6):1262–76. Epub 2013/11/08. https://doi.org/10.1111/mmi.12432 PMID:
24134710; PubMed Central PMCID: PMCPMC3881292.
21. Lim B, Beyhan S, Meir J, Yildiz FH. Cyclic-diGMP signal transduction systems in Vibrio cholerae: modu-
lation of rugosity and biofilm formation. Mol Microbiol. 2006; 60(2):331–48. https://doi.org/10.1111/j.
1365-2958.2006.05106.x PMID: 16573684.
22. Beyhan S, Tischler AD, Camilli A, Yildiz FH. Transcriptome and phenotypic responses of Vibrio cho-
lerae to increased cyclic di-GMP level. J Bacteriol. 2006; 188(10):3600–13. https://doi.org/10.1128/JB.
188.10.3600-3613.2006 PMID: 16672614; PubMed Central PMCID: PMCPMC1482859.
23. Jones CJ, Utada A, Davis KR, Thongsomboon W, Zamorano Sanchez D, Banakar V, et al. C-di-GMP
Regulates Motile to Sessile Transition by Modulating MshA Pili Biogenesis and Near-Surface Motility
Behavior in Vibrio cholerae. PLoS Pathog. 2015; 11(10):e1005068. Epub 2015/10/27. https://doi.org/
10.1371/journal.ppat.1005068 PMID: 26505896; PubMed Central PMCID: PMCPMC4624765.
24. Srivastava D, Harris RC, Waters CM. Integration of cyclic di-GMP and quorum sensing in the control of
vpsT and aphA in Vibrio cholerae. J Bacteriol. 2011; 193(22):6331–41. Epub 2011/09/16. https://doi.
org/10.1128/JB.05167-11 PMID: 21926235; PubMed Central PMCID: PMCPMC3209240.
25. Krasteva PV, Fong JC, Shikuma NJ, Beyhan S, Navarro MV, Yildiz FH, et al. Vibrio cholerae VpsT regu-
lates matrix production and motility by directly sensing cyclic di-GMP. Science. 2010; 327(5967):866–8.
https://doi.org/10.1126/science.1181185 PMID: 20150502; PubMed Central PMCID:
PMCPMC2828054.
26. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M. Cyclic diguanylate is a ubiquitous signaling mole-
cule in bacteria: insights into biochemistry of the GGDEF protein domain. J Bacteriol. 2005; 187
(5):1792–8. https://doi.org/10.1128/JB.187.5.1792-1798.2005 PMID: 15716451; PubMed Central
PMCID: PMCPMC1064016.
27. Galperin MY, Nikolskaya AN, Koonin EV. Novel domains of the prokaryotic two-component signal trans-
duction systems. FEMS Microbiol Lett. 2001; 203(1):11–21. PMID: 11557134.
28. Conner JG, Zamorano-Sa´nchez D, Park JH, Sondermann H, Yildiz FH. The ins and outs of cyclic di-
GMP signaling in Vibrio cholerae. Curr Opin Microbiol. 2017; 36:20–9. Epub 2017/02/05. https://doi.org/
10.1016/j.mib.2017.01.002 PMID: 28171809; PubMed Central PMCID: PMCPMC5534393.
29. Beyhan S, Yildiz FH. Smooth to rugose phase variation in Vibrio cholerae can be mediated by a single
nucleotide change that targets c-di-GMP signalling pathway. Mol Microbiol. 2007; 63(4):995–1007.
https://doi.org/10.1111/j.1365-2958.2006.05568.x PMID: 17233827.
30. Shikuma NJ, Fong JC, Yildiz FH. Cellular levels and binding of c-di-GMP control subcellular localization
and activity of the Vibrio cholerae transcriptional regulator VpsT. PLoS Pathog. 2012; 8(5):e1002719.
Epub 2012/05/24. https://doi.org/10.1371/journal.ppat.1002719 PMID: 22654664; PubMed Central
PMCID: PMCPMC3359988.
31. Dinh J, Angeloni JT, Pederson DB, Wang X, Cao M, Dong Y. Cranberry extract standardized for
proanthocyanidins promotes the immune response of Caenorhabditis elegans to Vibrio cholerae
through the p38 MAPK pathway and HSF-1. PLoS One. 2014; 9(7):e103290. Epub 2014/07/25. https://
doi.org/10.1371/journal.pone.0103290 PMID: 25062095; PubMed Central PMCID: PMCPMC4111578.
32. Tischler AD, Camilli A. Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol
Microbiol. 2004; 53(3):857–69. https://doi.org/10.1111/j.1365-2958.2004.04155.x PMID: 15255898;
PubMed Central PMCID: PMCPMC2790424.
33. Thelin KH, Taylor RK. Toxin-coregulated pilus, but not mannose-sensitive hemagglutinin, is required for
colonization by Vibrio cholerae O1 El Tor biotype and O139 strains. Infect Immun. 1996; 64(7):2853–6.
PMID: 8698524; PubMed Central PMCID: PMCPMC174155.
34. Vance RE, Zhu J, Mekalanos JJ. A constitutively active variant of the quorum-sensing regulator LuxO
affects protease production and biofilm formation in Vibrio cholerae. Infect Immun. 2003; 71(5):2571–6.
https://doi.org/10.1128/IAI.71.5.2571-2576.2003 PMID: 12704130; PubMed Central PMCID:
PMCPMC153284.
35. Albert MJ, Siddique AK, Islam MS, Faruque AS, Ansaruzzaman M, Faruque SM, et al. Large outbreak
of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet. 1993; 341(8846):704. PMID:
8095621.
36. Ramamurthy T, Garg S, Sharma R, Bhattacharya SK, Nair GB, Shimada T, et al. Emergence of novel
strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet. 1993; 341
(8846):703–4. PMID: 8095620.
37. Prabu GR, Gnanamani A, Sadulla S. Guaijaverin—a plant flavonoid as potential antiplaque agent
against Streptococcus mutans. J Appl Microbiol. 2006; 101(2):487–95. https://doi.org/10.1111/j.1365-
2672.2006.02912.x PMID: 16882158.
Cranberry extract inhibits Vibrio cholerae biofilm formation
PLOS ONE | https://doi.org/10.1371/journal.pone.0207056 November 7, 2018 17 / 19
38. Miller J. Experiments in Molecular Genetics. Cold Spring Harbor, NY: Cold Spring Harbor laboratory
Press.; 1972.
39. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc.
2008; 3(6):1101–8. PMID: 18546601.
40. Nakayama S, Kelsey I, Wang J, Roelofs K, Stefane B, Luo Y, et al. Thiazole orange-induced c-di-GMP
quadruplex formation facilitates a simple fluorescent detection of this ubiquitous biofilm regulating mole-
cule. J Am Chem Soc. 2011; 133(13):4856–64. Epub 2011/03/08. https://doi.org/10.1021/ja1091062
PMID: 21384923.
41. Watnick PI, Kolter R. Steps in the development of a Vibrio cholerae El Tor biofilm. Mol Microbiol. 1999;
34(3):586–95. PMID: 10564499; PubMed Central PMCID: PMCPMC2860543.
42. van der Mei HC, Roseberg M, Busscher HJ. Microbial Cell Surface Analysis: Structural and Physico-
chemical Methods: VCH; 1991.
43. Dahlba¨ck B, Hermansson M, Kjelleberg S, Norkrans B. The hydrophobicity of bacteria—an important
factor in their initial adhesion at the air-water interface. Arch Microbiol. 1981; 128(3):267–70. PMID:
7212931.
44. Hollenbeck EC, Fong JC, Lim JY, Yildiz FH, Fuller GG, Cegelski L. Molecular determinants of mechani-
cal properties of V. cholerae biofilms at the air-liquid interface. Biophys J. 2014; 107(10):2245–52.
https://doi.org/10.1016/j.bpj.2014.10.015 PMID: 25418293; PubMed Central PMCID:
PMCPMC4241461.
45. Ali A, Johnson JA, Franco AA, Metzger DJ, Connell TD, Morris JG, et al. Mutations in the extracellular
protein secretion pathway genes (eps) interfere with rugose polysaccharide production in and motility of
Vibrio cholerae. Infect Immun. 2000; 68(4):1967–74. PMID: 10722590; PubMed Central PMCID:
PMCPMC97374.
46. Feldman M, Weiss EI, Ofek I, Steinberg D. Interference of cranberry constituents in cell-cell signaling
system of Vibrio harveyi. Curr Microbiol. 2009; 59(4):469–74. Epub 2009/08/11. https://doi.org/10.
1007/s00284-009-9462-3 PMID: 19669834.
47. Harjai K, Gupta RK, Sehgal H. Attenuation of quorum sensing controlled virulence of Pseudomonas
aeruginosa by cranberry. Indian J Med Res. 2014; 139(3):446–53. PMID: 24820840; PubMed Central
PMCID: PMCPMC4069740.
48. Maisuria VB, Los Santos YL, Tufenkji N, De´ziel E. Cranberry-derived proanthocyanidins impair viru-
lence and inhibit quorum sensing of Pseudomonas aeruginosa. Sci Rep. 2016; 6:30169. Epub 2016/08/
09. https://doi.org/10.1038/srep30169 PMID: 27503003; PubMed Central PMCID: PMCPMC4977528.
49. Daglia M. Polyphenols as antimicrobial agents. Curr Opin Biotechnol. 2012; 23(2):174–81. Epub 2011/
09/16. https://doi.org/10.1016/j.copbio.2011.08.007 PMID: 21925860.
50. Slobodnı´kova´ L, Fialova´ S, Rendekova´ K, Kova´č J, Mučaji P. Antibiofilm Activity of Plant Polyphenols.
Molecules. 2016; 21(12). Epub 2016/12/13. https://doi.org/10.3390/molecules21121717 PMID:
27983597.
51. Pappas E, Schaich KM. Phytochemicals of cranberries and cranberry products: characterization, poten-
tial health effects, and processing stability. Crit Rev Food Sci Nutr. 2009; 49(9):741–81. https://doi.org/
10.1080/10408390802145377 PMID: 20443158.
52. Coˆte´ J, Caillet S, Doyon G, Sylvain JF, Lacroix M. Analyzing cranberry bioactive compounds. Crit Rev
Food Sci Nutr. 2010; 50(9):872–88. https://doi.org/10.1080/10408390903042069 PMID: 20924868.
53. Coˆte´ J, Caillet S, Doyon G, Sylvain JF, Lacroix M. Bioactive compounds in cranberries and their biologi-
cal properties. Crit Rev Food Sci Nutr. 2010; 50(7):666–79. https://doi.org/10.1080/
10408390903044107 PMID: 20694928.
54. Walker EB, Barney DP, Mickelsen JN, Walton RJ, Mickelsen RA. Cranberry concentrate: UTI prophy-
laxis. J Fam Pract. 1997; 45(2):167–8. PMID: 9267377.
55. Howell AB, Reed JD, Krueger CG, Winterbottom R, Cunningham DG, Leahy M. A-type cranberry
proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochemistry. 2005; 66
(18):2281–91. https://doi.org/10.1016/j.phytochem.2005.05.022 PMID: 16055161.
56. Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections.
Mol Nutr Food Res. 2007; 51(6):732–7. https://doi.org/10.1002/mnfr.200700038 PMID: 17487930.
57. Steinberg D, Feldman M, Ofek I, Weiss EI. Effect of a high-molecular-weight component of cranberry
on constituents of dental biofilm. J Antimicrob Chemother. 2004; 54(1):86–9. Epub 2004/05/28. https://
doi.org/10.1093/jac/dkh254 [pii]. PMID: 15163648.
58. Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice on attachment of oral
streptococci and biofilm formation. Oral Microbiol Immunol. 2004; 19(3):150–4. https://doi.org/10.1111/
j.0902-0055.2004.00130.x PMID: 15107065.
Cranberry extract inhibits Vibrio cholerae biofilm formation
PLOS ONE | https://doi.org/10.1371/journal.pone.0207056 November 7, 2018 18 / 19
59. Yamanaka A, Kouchi T, Kasai K, Kato T, Ishihara K, Okuda K. Inhibitory effect of cranberry polyphenol
on biofilm formation and cysteine proteases of Porphyromonas gingivalis. J Periodontal Res. 2007; 42
(6):589–92. https://doi.org/10.1111/j.1600-0765.2007.00982.x PMID: 17956474.
60. Bodet C, Grenier D, Chandad F, Ofek I, Steinberg D, Weiss EI. Potential oral health benefits of cran-
berry. Crit Rev Food Sci Nutr. 2008; 48(7):672–80. https://doi.org/10.1080/10408390701636211 PMID:
18663617.
61. Burger O, Weiss E, Sharon N, Tabak M, Neeman I, Ofek I. Inhibition of Helicobacter pylori adhesion to
human gastric mucus by a high-molecular-weight constituent of cranberry juice. Crit Rev Food Sci Nutr.
2002; 42(3 Suppl):279–84. Epub 2002/06/13. https://doi.org/10.1080/10408390209351916 PMID:
12058986.
62. Koo H, Nino de Guzman P, Schobel BD, Vacca Smith AV, Bowen WH. Influence of cranberry juice on
glucan-mediated processes involved in Streptococcus mutans biofilm development. Caries Res. 2006;
40(1):20–7. https://doi.org/10.1159/000088901 PMID: 16352876.
63. Labrecque J, Bodet C, Chandad F, Grenier D. Effects of a high-molecular-weight cranberry fraction on
growth, biofilm formation and adherence of Porphyromonas gingivalis. J Antimicrob Chemother. 2006;
58(2):439–43. Epub 2006/05/30. https://doi.org/10.1093/jac/dkl220 PMID: 16735419.
64. Babu J, Blair C, Jacob S, Itzhak O. Inhibition of Streptococcus gordonii metabolic activity in biofilm by
cranberry juice high-molecular-weight component. J Biomed Biotechnol. 2012; 2012:590384. Epub
2012/01/18. https://doi.org/10.1155/2012/590384 PMID: 22318895; PubMed Central PMCID:
PMCPMC3270421.
65. Kim D, Hwang G, Liu Y, Wang Y, Singh AP, Vorsa N, et al. Cranberry Flavonoids Modulate Cariogenic
Properties of Mixed-Species Biofilm through Exopolysaccharides-Matrix Disruption. PLoS One. 2015;
10(12):e0145844. Epub 2015/12/29. https://doi.org/10.1371/journal.pone.0145844 PMID: 26713438;
PubMed Central PMCID: PMCPMC4699891.
66. Tapiainen T, Jauhiainen H, Jaakola L, Salo J, Sevander J, Ika¨heimo I, et al. Biofilm formation and viru-
lence of uropathogenic Escherichia coli in urine after consumption of cranberry-lingonberry juice. Eur J
Clin Microbiol Infect Dis. 2012; 31(5):655–62. Epub 2011/08/07. https://doi.org/10.1007/s10096-011-
1355-2 PMID: 21822564.
67. Rane HS, Bernardo SM, Howell AB, Lee SA. Cranberry-derived proanthocyanidins prevent formation of
Candida albicans biofilms in artificial urine through biofilm- and adherence-specific mechanisms. J Anti-
microb Chemother. 2014; 69(2):428–36. Epub 2013/10/10. https://doi.org/10.1093/jac/dkt398 PMID:
24114570; PubMed Central PMCID: PMCPMC3937597.
68. Wojnicz D, Tichaczek-Goska D, Korzekwa K, Kicia M, Hendrich AB. Study of the impact of cranberry
extract on the virulence factors and biofilm formation by Enterococcus faecalis strains isolated from uri-
nary tract infections. Int J Food Sci Nutr. 2016; 67(8):1005–16. Epub 2016/07/26. https://doi.org/10.
1080/09637486.2016.1211996 PMID: 27456160.
69. Leshem R, Maharshak I, Ben Jacob E, Ofek I, Kremer I. The effect of nondialyzable material (NDM)
cranberry extract on formation of contact lens biofilm by Staphylococcus epidermidis. Invest Ophthalmol
Vis Sci. 2011; 52(7):4929–34. Epub 2011/07/01. https://doi.org/10.1167/iovs.10-5335 PMID:
21467179.
70. Ulrey RK, Barksdale SM, Zhou W, van Hoek ML. Cranberry proanthocyanidins have anti-biofilm proper-
ties against Pseudomonas aeruginosa. BMC Complement Altern Med. 2014; 14:499. Epub 2014/12/16.
https://doi.org/10.1186/1472-6882-14-499 PMID: 25511463; PubMed Central PMCID:
PMCPMC4320558.
71. Jenal U, Reinders A, Lori C. Cyclic di-GMP: second messenger extraordinaire. Nat Rev Microbiol.
2017; 15(5):271–84. Epub 2017/02/06. https://doi.org/10.1038/nrmicro.2016.190 PMID: 28163311.
Cranberry extract inhibits Vibrio cholerae biofilm formation
PLOS ONE | https://doi.org/10.1371/journal.pone.0207056 November 7, 2018 19 / 19
